2 completed, 2 unknown. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 2, Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Genelabs Technologies: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids Prasterone (GL701) - Systemic Lupus Erythematosus | Phase 3 | Completed | Genelabs Technologies | 114 | 2003-07-01 | 2008-01-14 |
| To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids Prasterone (GL701) - Lupus | Phase 3 | Unknown | Genelabs Technologies | 155 | 2002-12-01 | 2008-01-07 |
| Study of GL701 in Men With Systemic Lupus Erythematosus GL701 - Systemic Lupus Erythematosus | Phase 3 | Unknown | Genelabs Technologies | 40 | 1998-03-01 | 2005-06-24 |
| A Randomized Phase II Efficacy, Activity and Safety Study of GLQ223 Alone and in Combination With Zidovudine in Symptomatic HIV-Infected Patients Without Prior Treatment With GLQ223 or Trichosanthin Trichosanthin, Zidovudine - HIV Infections | Phase 2 | Completed | Genelabs Technologies | 2005-06-24 |
Lupus Erythematosus, Systemic (3) · Bone Diseases, Metabolic (2) · AIDS-Related Complex (1) · Acquired Immunodeficiency Syndrome (1) · HIV Infections (1)
Dehydroepiandrosterone (2) · GL-701 (2) · Trichosanthin (1) · Zidovudine (1)
United States (4) · Mexico (2)